![Kenneth Kovan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kovan
Oprichter bij
BIOVAXYS TECHNOLOGY CORP.
Vermogen: 102 881 $ op 31-07-2026
Profiel
Kenneth E.
Kovan is the founder of AVAX Technologies, Inc., founded in 1990.
Mr. Kovan is the founder of Bingham Hill Ventures, founded in 2012, holding the title of Managing Principal.
Mr. Kovan is also the founder of BioVaxys Technology Corp.,BioVaxys LLC.
Mr. Kovan is currently the President of Chaperone Technologies, Inc. Former positions include Principal at Thomas Jefferson University, Principal at GSK Plc, Principal at Wyeth-Ayerst Research, and Partner at Revvity Discovery Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-10-2025 | 935.286 ( 3,21% ) | 102 881 $ | 31-07-2026 |
Actieve functies van Kenneth Kovan
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOVAXYS TECHNOLOGY CORP. | Oprichter | - |
Chaperone Technologies, Inc.
 Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Develops novel products for infectious diseases | President | - |
BioVaxys LLC
 BioVaxys LLC BiotechnologyHealth Technology Develops viral oncology and therapeutic platforms | Oprichter | - |
Bingham Hill Ventures | Oprichter | 01-01-2012 |
Eerdere bekende functies van Kenneth Kovan
| Bedrijven | Functie | Einde |
|---|---|---|
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AVAX TECHNOLOGIES, INC. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
AVAX Technologies, Inc.
 AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Wyeth-Ayerst Research | |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Develops novel products for infectious diseases | Health Technology |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Commercial Services |
BioVaxys Technology Corp.
 BioVaxys Technology Corp. Other Metals/MineralsNon-Energy Minerals Provides mining exploration services | Non-Energy Minerals |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology Develops viral oncology and therapeutic platforms | Health Technology |
Bingham Hill Ventures |
